Specific ablation of TBK1 in adipocytes reduced HFD-induced obesity but showed glucose intolerance and insulin resistance (Zhao et al., 2018; Shin and Choi, 2019), so specific inhibitors on IKKε should be necessary to avoid the side effects. Here, IKBKE is linked to obesity disorder.